Los Angeles Capital Management LLC cut its position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 47.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 43,109 shares of the company's stock after selling 38,168 shares during the quarter. Los Angeles Capital Management LLC owned about 0.12% of Harrow worth $1,938,000 at the end of the most recent reporting period.
A number of other institutional investors have also bought and sold shares of the company. nVerses Capital LLC bought a new stake in shares of Harrow during the 2nd quarter valued at about $33,000. Allspring Global Investments Holdings LLC grew its position in shares of Harrow by 2,730.7% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 2,123 shares of the company's stock worth $44,000 after buying an additional 2,048 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Harrow by 21.5% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,283 shares of the company's stock valued at $57,000 after acquiring an additional 227 shares in the last quarter. Hills Bank & Trust Co bought a new position in Harrow during the third quarter worth $107,000. Finally, Bayesian Capital Management LP acquired a new stake in Harrow in the first quarter worth $185,000. Institutional investors own 72.76% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the stock. Lake Street Capital upped their price objective on shares of Harrow from $45.00 to $55.00 and gave the company a "buy" rating in a report on Friday, October 4th. Craig Hallum increased their price target on Harrow from $45.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, October 4th. Finally, B. Riley restated a "buy" rating and set a $50.00 price objective on shares of Harrow in a report on Thursday, August 29th.
Get Our Latest Stock Analysis on HROW
Harrow Stock Down 17.3 %
Shares of NASDAQ:HROW traded down $8.94 during mid-day trading on Thursday, hitting $42.86. 2,463,937 shares of the company traded hands, compared to its average volume of 507,798. The stock has a market cap of $1.52 billion, a P/E ratio of -45.60 and a beta of 0.76. The stock has a 50-day moving average price of $47.84 and a two-hundred day moving average price of $32.00. Harrow, Inc. has a 12-month low of $7.81 and a 12-month high of $59.23. The company has a current ratio of 2.60, a quick ratio of 2.43 and a debt-to-equity ratio of 3.18.
About Harrow
(
Free Report)
Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.
See Also
Before you consider Harrow, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Harrow wasn't on the list.
While Harrow currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
